These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 25124060)
21. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography. Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of dual time-point 18 F-FDG PET/CT versus single time-point imaging for detection of mediastinal nodal metastasis in non-small cell lung cancer patients: a meta-analysis. Shen G; Hu S; Deng H; Jia Z Acta Radiol; 2015 Jun; 56(6):681-7. PubMed ID: 24917609 [TBL] [Abstract][Full Text] [Related]
23. Lymph node staging in lung cancer using [18F]FDG-PET. Halter G; Buck AK; Schirrmeister H; Aksoy E; Liewald F; Glatting G; Neumaier B; Mühling B; Nüssle-Kügele K; Hetzel M; Sunder-Plassmann L; Reske SN Thorac Cardiovasc Surg; 2004 Apr; 52(2):96-101. PubMed ID: 15103582 [TBL] [Abstract][Full Text] [Related]
24. Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancer. Shingyoji M; Nakajima T; Yoshino M; Yoshida Y; Ashinuma H; Itakura M; Tatsumi K; Iizasa T Ann Thorac Surg; 2014 Nov; 98(5):1762-7. PubMed ID: 25149044 [TBL] [Abstract][Full Text] [Related]
25. Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer. Xu N; Wang M; Zhu Z; Zhang Y; Jiao Y; Fang W Chin Med J (Engl); 2014; 127(4):607-13. PubMed ID: 24534208 [TBL] [Abstract][Full Text] [Related]
26. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study. Kim BT; Lee KS; Shim SS; Choi JY; Kwon OJ; Kim H; Shim YM; Kim J; Kim S Radiology; 2006 Nov; 241(2):501-9. PubMed ID: 16966480 [TBL] [Abstract][Full Text] [Related]
27. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study. De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747 [TBL] [Abstract][Full Text] [Related]
28. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer. Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985 [TBL] [Abstract][Full Text] [Related]
29. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Gould MK; Kuschner WG; Rydzak CE; Maclean CC; Demas AN; Shigemitsu H; Chan JK; Owens DK Ann Intern Med; 2003 Dec; 139(11):879-92. PubMed ID: 14644890 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer. Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198 [TBL] [Abstract][Full Text] [Related]
31. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Kim YK; Lee KS; Kim BT; Choi JY; Kim H; Kwon OJ; Shim YM; Yi CA; Kim HY; Chung MJ Cancer; 2007 Mar; 109(6):1068-77. PubMed ID: 17311309 [TBL] [Abstract][Full Text] [Related]
32. [Positron emission tomography/computed tomography for lung cancer staging]. Ladrón de Guevara H D; Furnaro L F; Yévenes A S; Clavero R JM; Lazo P D; Rodríguez D P; Piottante B A; Pefaur D R; Pardo B C Rev Med Chil; 2015 Jan; 143(1):22-9. PubMed ID: 25860265 [TBL] [Abstract][Full Text] [Related]
33. Contrast enhanced CT versus integrated PET-CT in pre-operative nodal staging of non-small cell lung cancer. Ceylan N; Doğan S; Kocaçelebi K; Savaş R; Çakan A; Çağrici U Diagn Interv Radiol; 2012; 18(5):435-40. PubMed ID: 22374706 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients. Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912 [TBL] [Abstract][Full Text] [Related]
35. The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma. Lu P; Sun Y; Sun Y; Yu L Lung Cancer; 2014 Jul; 85(1):53-8. PubMed ID: 24792334 [TBL] [Abstract][Full Text] [Related]
36. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794 [TBL] [Abstract][Full Text] [Related]
37. [Prognostic value of PET/CT in lung cancer: retrospective analysis of 47 patients]. de Guevara DL; Fuentes A; Fariña C; Corral C; Pefaur R Rev Med Chil; 2013 Jan; 141(1):41-8. PubMed ID: 23732413 [TBL] [Abstract][Full Text] [Related]
38. Role of preoperative PET-CT in assessing mediastinal and hilar lymph node status in early stage lung cancer. Lin WY; Hsu WH; Lin KH; Wang SJ J Chin Med Assoc; 2012 May; 75(5):203-8. PubMed ID: 22632985 [TBL] [Abstract][Full Text] [Related]
39. The mediastinal staging accuracy of 18F-Fluorodeoxyglycose positron emission tomography/computed tomography in non-small cell lung cancer with variable time intervals to surgery. Booth K; Hanna GG; McGonigle N; McManus KG; McGuigan J; O'Sullivan J; Lynch T; McAleese J Ulster Med J; 2013 May; 82(2):75-81. PubMed ID: 24082283 [TBL] [Abstract][Full Text] [Related]
40. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer. Ose N; Sawabata N; Minami M; Inoue M; Shintani Y; Kadota Y; Okumura M Eur J Cardiothorac Surg; 2012 Jul; 42(1):89-92. PubMed ID: 22290887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]